The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy

Wang T, Lin F, Huang Y, Qian G, Yu W, Hu H, Ji T, Tang L, Yao Y

Cancer Management and Research 2022, 14:2945-2952

Published Date: 4 October 2022